Hypertension associated with osteoporosis in female patients of the Seguro Social de Salud hospital, Trujillo
DOI:
https://doi.org/10.24265/horizmed.2022.v22n4.04Keywords:
Hypertension, Osteoporosis, Hypercholesterolemia, DensitometryAbstract
Objective: To determine if hypertension is associated with osteoporosis in female patients of Seguro Social de Salud (EsSalud) Hospital I in Trujillo.
Materials and methods: An observational, analytical and cross-sectional study, which included 351 female patients treated in the Internal Medicine Unit of EsSalud Hospital I Florencia de Mora, Trujillo, from 2016 to 2019. According to the screening criteria, patients were divided into two groups—175 with hypertension and 176 without hypertension—to determine the number of patients with osteoporosis. The data was analyzed with Pearson’s chi-square test using IBM SPSS Statistics V26 to perform the statistical analysis and present the results in graphs and tables in Microsoft Excel Windows 10.
Results: It was found that the prevalence of osteoporosis with hypertension accounted for 31.4 %, while that of osteoporosis without hypertension was 1.7 %. This shows that the prevalence of osteoporosis in women with hypertension is statistically significant (p < 0.001) with respect to women without hypertension. Regarding the analysis of the intervening variables, age (p < 0.001), cholesterol (p < 0.001) and coffee (p < 0.001) were statistically significant. Variables such as type 2 diabetes mellitus, sex, obesity, anemia, triglycerides and smoking were not statistically significant.
Conclusions: Hypertension is associated with osteoporosis as well as with the intervening variables age, cholesterol and coffee, as they were statistically significant.
Downloads
References
Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021; 18(11): 785-802.
NCD-RisC. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19,1 million participants. Lancet. 2017; 389(10064): 37-55.
Lacruz ME, Kluttig A, Hartwig S, Löer M, Tiller D, Greiser KH, et al. Prevalence and incidence of hypertension in the general adult population. Medicine. 2015; 94(22): e952.
Instituto Nacional de Estadística e Informática. Programa de Enfermedades No Transmisibles [Internet]. Lima: Inei; 2019. Disponble en: https://proyectos.inei.gob.pe/endes/2019/SALUD/ENFERMEDADES_ENDES_2019.pdf
Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update. Endocr Pract. 2020; 26(Suppl. 1): 1-46.
Radominski SC, Bernardo W, Paula AP, Albergaria BH, Moreira C, Fernandes CE, et al. Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Rev Bras Reumatol Engl Ed. 2017; 57(Suppl. 2): 452-66.
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71(6): 1629-324.
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018; 39(33): 3021-104.
Basile J, Bloch MJ. Overview of hypertension in adults [Internet]. UpToDate; 2021. Disponible en: https://www.uptodate.com/contents/overview-of-hypertension-in-adults?source=history_widget
Hernández-Vásquez A, Rojas-Roque C, Santero M, Ruiz-Maza JC, Casas-Bendezú M, Miranda JJ. ¿Qué representa cambiar el umbral diagnóstico de la hipertensión arterial? Guías ACC/AHA 2017 y su aplicación en Perú. Rev Méd Chile. 2019; 147(5): 545-56.
Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019; 30(1): 3-44.
Bijelic R, Milicevic S, Balaban J. Risk factors for osteoporosis in postmenopausal women. Med Arch. 2017; 71(1): 25-8.
Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen TV. Association between hypertension and fragility fracture: a longitudinal study. Osteoporos Int. 2014; 25(1): 97-103.
Ma X, Xia H, Wang J, Zhu X, Huang F, Lu L, et al. Re-fracture and correlated risk factors in patients with osteoporotic vertebral fractures. J Bone Miner Metab. 2019; 37(4): 722-8.
Hong AR, Kim JH, Lee JH, Kim SW, Shin CS. Metabolic characteristics of subjects with spine–femur bone mineral density discordances: the Korean National Health and Nutrition Examination Survey (KNHANES 2008–2011). J Bone Miner Metab. 2019; 37(5): 835-43.
Manrique N, Pereira CCS, Luvizuto ER, Sánchez MDPR, Okamoto T, Okamoto R, et al. Hypertension modifies OPG, RANK, and RANKL expression during the dental socket bone healing process in spontaneously hypertensive rats. Clin Oral Investig. 2015; 19(6): 1319-27.
De Barros TL, Brito VGB, do Amaral CCF, Chaves-Neto AH, Campanelli AP, Oliveira SHP. Osteogenic markers are reduced in bone-marrow mesenchymal cells and femoral bone of young spontaneously hypertensive rats. Life Sci. 2016; 146: 174-83.
Delden JJMv, Graaf RVD. Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans. JAMA. 2017; 317(2): 135-6.
NCD-RisC. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304): 957-80.
Zhang Q, Zhou J, Wang Q, Lu C, Xu Y, Cao H, et al. Association between bone mineral density and lipid profile in Chinese women. Clin Interv Aging. 2020; 15: 1649-64.
Chai H, Ge J, Li L, Li J, Ye Y. Hypertension is associated with osteoporosis: a case-control study in Chinese postmenopausal women. BMC Musculoskelet Disord. 2021; 22(1): 253.
Saravi B, Vollmer A, Lang G, Adolphs N, Li Z, Giers V, et al. Impact of renin-angiotensin system inhibitors and beta-blockers on dental implant stability. Int J Implant Dent. 2021; 7: 31.
Zhao J, Yang H, Chen B, Zhang R. The skeletal renin-angiotensin system: A potential therapeutic target for the treatment of osteoarticular diseases. Int Immunopharmacol. 2019; 72: 258-63.
Rojas J, Olivar LC, Castillo MC, Martínez MS, Wilches-Durán S, Graterol M, et al. Hormona paratiroidea, aldosterona e hipertensión arterial ¿una amenaza infravalorada? Rev Latinoam Hipertens. 2017; 12(1): 1-18.
Santiago-Peña LF. Fisiología de las glándulas paratiroides. Disfunción y parámetros funcionales de laboratorio en paratiroides. Rev ORL. 2020; 11(3): 341-5.
He B, Yin L, Zhang M, Lyu Q, Quan Z, Ou Y. Causal effect of blood pressure on bone mineral density and fracture: A mendelian randomization study. Front Endocrinol. 2021; 12: 716681.
Chawla J, Sharma N, Arora D, Arora M, Shukla L. Bone densitometry status and its associated factors in peri and post menopausal females: A cross sectional study from a tertiary care centre in India. Taiwan J Obstet Gynecol. 2018; 57(1): 100-5.
Alay I, Kaya C, Cengiz H, Yildiz S, Ekin M, Yasar L. The relation of body mass index, menopausal symptoms, and lipid profile with bone mineral density in postmenopausal women. Taiwan J Obstet Gynecol. 2020; 59(1): 61-6.
Dai Z, Jin A, Soh AZ, Ang LW, Yuan JM, Koh WP. Coffee and tea drinking in relation to risk of hip fracture in the Singapore Chinese Health Study. Bone. 2018; 112: 51-7.
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017; 360: k194.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Jeanpierre De La Cruz-Burgos, Víctor Bardales-Zuta
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
